Skip to content

Clinical trials

Homozygous Familial Hypercholesterolemia trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Homozygous Familial Hypercholesterolemia Country / region: South Africa Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20091
20122
20162
20172
20182
20193
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Amgen3
Regeneron Pharmaceuticals3
Aegerion Pharmaceuticals, Inc.2
Arrowhead Pharmaceuticals2
Kastle Therapeutics, LLC2
LIB Therapeutics LLC1
The Medicines Company1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Homozygous Familial Hypercholesterolemia19
Hypercholesterolemia9
Hyperlipoproteinemia Type II8
Dyslipidemias3
Hyperlipidemias3
Congenital Abnormalities2
Genetic Diseases, Inborn2
Hyperlipoproteinemias2
Infant, Newborn, Diseases2
Lipid Metabolism Disorders2

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.